Revealense

Company Overview

Snapshot

Founded in November 2021 by Dov Donin, Revealense operates with 1–10 employees and has raised $4.14M across one funding round. The company recently partnered with Sheba ARC to launch AI-powered home neurology diagnostics in August 2025.

Business overview

Revealense is developing a neurological-AI engine designed to understand human mental states and conditions by unifying biology, psychology, culture, and context into a behavioral intelligence framework. The company's patented methodology correlates content, cultural background, and contextual events to reveal not only what a person expresses but also their concealed thoughts, feelings, and real-time neurological responses. Primarily serving the defense and healthcare domains, Revealense provides context-aware, non-invasive, human-centric assessment tools. Its technology, built on over 14,000 contextualized video sessions and 25 million annotated behavioral frames, offers multimodal video analysis, behavioral science, and culturally adaptable, clinically validated AI to decode human behavior.

Strategic signal

In August 2025, Revealense partnered with Sheba ARC to launch AI-powered home neurology diagnostics. This collaboration signifies a major step in validating Revealense's AI technology for clinical applications, particularly in identifying conditions like autism and ADHD from a home setting. For investors, this indicates strong market traction and a potential for rapid expansion within the digital healthcare sector, demonstrating the company's ability to translate its research into tangible, impactful solutions.

Company Intelligence Q&A

What is Revealense's primary focus?

Revealense focuses on developing a neurological-AI engine to understand human mental states and conditions, integrating biology, psychology, culture, and context into a behavioral intelligence framework.

When was Revealense founded and by whom?

Revealense was founded in November 2021 by Dov Donin.

What significant partnership did Revealense announce in August 2025?

In August 2025, Revealense partnered with Sheba ARC to launch AI-powered home neurology diagnostics, aiming to transform neurological diagnosis and patient care.

What is the total capital raised by Revealense?

Revealense has raised a total of $4.14M across one funding round.

Which sectors does Revealense primarily serve?

Revealense primarily serves the defense and healthcare domains, where accurate human assessment and neurological diagnostics are critical.